Start main content

MSC Microspheres for Regenerative Medicine

MSC Microspheres for Regenerative Medicine
Therapeutic Biologics

Key Problem and Market Opportunity

•Stem cell-based therapy (SCT) presents a promising approach for regenerative medicine and tissue engineering

•Using mesenchymal stem cells (MSC) in SCT is more socially and ethically acceptable than embryonic stem cells

•However, nowadays there is no effective delivery device for SCT to have satisfactory functional outcomes

Key Advantages of the Technology

Technology Section Slider 1
Technology Section Slider 2
Technology Section Slider 3
Technology Section Slider 4

•Self-assembled collagen-MSC microspheres

•Controlled sphere sized: 150-300µm in diameter

•MSC number in the spheres can be controlled for various applications

•Encapsulated MSCs are protected by a dense meshwork of collagen fibrils creating a physiologically relevant permissive environment

Potential Product and Services

Cell-based therapy

Development Status and IP Strength

•Animal testing completed
•Open to Licensing
•PCT Application No: PCT/IB2007/004413
•Published Date: 2008-06-26

Work with us